Načítá se...
Is Left Ventricular Hypertrophy a Modifiable Risk Factor in ESRD
PURPOSE OF REVIEW: Left ventricular hypertrophy (LVH) is common in ESRD and has been advocated as a therapeutic target. We review considerations for targeting LVH as a modifiable risk factor in ESRD. RECENT FINDINGS: Pathologic myocardial changes underlying LVH provide an ideal substrate for the spr...
Uloženo v:
| Vydáno v: | Curr Opin Nephrol Hypertens |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266593/ https://ncbi.nlm.nih.gov/pubmed/25295959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000067 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|